RASA2: A Protein Involved in Pain and Anxiety Regulation (G5922)

Target Name: RASA2

NCBI ID: G5922

RASA2: A Protein Involved in Pain and Anxiety Regulation

RASA2 (GAP1M) is a protein that is expressed in various tissues throughout the body, including the brain. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling. RASA2 is known for its role in the regulation of pain, anxiety, and other inflammatory responses.

The GPCR family consists of four subfamilies: GPCR-A, GPCR-B, GPCR-C, and GPCR-D. RASA2 is a member of the GPCR-B subfamily, which is characterized by the presence of the extracellular domain (ECD), a transmembrane segment (TMS), and a unique N-terminus (NT).

The ECD of RASA2 consists of a highly conserved alpha-helices that are involved in the formation of the protein's transmembrane domain. The TMS is a short transmembrane segment that is involved in the formation of the protein's extracellular domain. The NT is a unique segment that is located at the N-terminus of the protein and is involved in the formation of the protein's transmembrane domain.

RASA2 is involved in the regulation of a wide range of physiological processes in the body, including pain, anxiety, and inflammation. It is known to play a critical role in the regulation of pain perception, with studies showing that RASA2 is involved in the modulation of pain sensitivity in various models of pain.

In addition to its role in pain regulation, RASA2 is also involved in the regulation of anxiety and other inflammatory responses. Studies have shown that RASA2 is involved in the regulation of anxiety-like behavior in various models of anxiety, with RASA2 being expressed in the brain and modulating the activity of neural circuits that are involved in anxiety regulation.

Given its involvement in the regulation of pain and anxiety, RASA2 is a promising drug target for the development of new treatments for these conditions. Studies have shown that RASA2 is involved in the regulation of pain sensitivity, anxiety, and inflammation, making it a potential target for small molecule inhibitors.

In addition to its potential as a drug target, RASA2 is also a potential biomarker for the diagnosis and monitoring of pain and anxiety disorders. Studies have shown that RASA2 is expressed in various tissues and cells throughout the body, including the brain, and that it is involved in the regulation of pain and anxiety responses.

Given its involvement in the regulation of pain and anxiety, RASA2 is a promising target for the development of new treatments for these conditions. Studies are being conducted to determine the full extent of RASA2's involvement in the regulation of pain and anxiety, as well as its potential as a biomarker for the diagnosis and monitoring of these conditions.

In conclusion, RASA2 (GAP1M) is a protein that is involved in the regulation of pain, anxiety, and other inflammatory responses. It is a member of the GPCR-B subfamily and is expressed in various tissues throughout the body. RASA2 is known for its role in the regulation of pain sensitivity and is a potential drug target for the development of new treatments for pain and anxiety disorders. In addition to its potential as a drug target, RASA2 is also a potential biomarker for the diagnosis and monitoring of these conditions. Further studies are being conducted to determine the full extent of RASA2's involvement in the regulation of pain and anxiety and to explore its potential as a biomarker for the diagnosis and monitoring of these conditions.

Protein Name: RAS P21 Protein Activator 2

Functions: Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4)

More Common Targets